Table 1.
Mean of inhibitory growth rate (%) of the pathogenic three F. oxysporum isolates with the smaller size (5 nm) of the rGO-CuO NPs.
| Pathogen | Treatment | Concentration | Inhibition Rate (%) | |||
|---|---|---|---|---|---|---|
| 4 Days | 6 Days | 8 Days | ||||
| F. oxysporum (FORL) | rGO-CuO nanocomposite | 1 mg/L | 92.35 ± 2.047 | 93.15 ± 1.09 | 92.37 ± 1.35 | |
| 10 mg/L | 92.90 ± 1.1 | 93.153 ± 1.09 | 93.7 ± 1.28 | |||
| 100 mg/L | 92.89 ± 1.13 | 93.17 ± 1.08 | 94.44 ± 0.0 | |||
| Controls | rGO | 1 g/L | 5.55 ± 0.0 | 8.33 ± 1.1 | 11.11 ± 0.0 | |
| CuO NPs | 1 g/L | 19.22 ± 0.0 | 22.22 ± 0.0 | 33.33 ± 1.1 | ||
| Kocide 2000 | 2.5 g/L | 65.3 ± 0.2 | 67.2 ± 0.4 | 68.3 ± 1.1 | ||
| F. oxysporum (FOC1) | rGO-CuO nanocomposite | 1 mg/L | 89.06 ± 0.31 | 92.35 ± 0.30 | 92.80 ± 0.3 | |
| 10 mg/L | 89.06 ± 0.31 | 92.36 ± 0.35 | 92.80 ± 0.33 | |||
| 100 mg/L | 89.08 ± 0.27 | 92.35 ± 0.35 | 92.80 ± 0.33 | |||
| Controls | rGO | 1 g/L | 2.27 ± 0.0 | 5.55 ± 1.1 | 8.33 ± 0.20 | |
| CuO NPs | 1 g/L | 25.00 ± 1.0 | 33.33 ± 1.1 | 38.88 ± 1.1 | ||
| Kocide 2000 | 2.5 g/L | 64.5 ± 0.5 | 69.2 ± 0.2 | 68.9 ± 0.4 | ||
| F. oxysporum (FOC2) | rGO-CuO nanocomposite | 1 mg/L | 85.95 ± 6.30 | 81.24 ± 7.1 | 83.34 ± 3.4 | |
| 10 mg/L | 87.13 ± 2.49 | 82.07 ± 1.8 | 82.13 ± 4.5 | |||
| 100 mg/L | 87.72 ± 2.8 | 88.77 ± 2.8 | 87.8 ± 2.5 | |||
| Controls | rGO | 1 g/L | 5.55 ± 0.0 | 8.33 ± 1.1 | 11.11 ± 0.0 | |
| CuO NPs | 1 g/L | 19.22 ± 0.0 | 22.22 ± 0.0 | 30.55 ± 0.0 | ||
| Kocide 2000 | 2.5 g/L | 63.3 ± 0.5 | 65.2 ± 0.4 | 70.5 ± 1.0 | ||